Episodes: 91
Frequency: Weekly
Rating: 4.5/5.0
Estimated listeners: 100 - 1,000
Listener location: Australia
YouTube: 3.3k subscribers
Instagram: 3.7k followers
Page updated: Nov 11, 2026 · How we check this data
Publicly listed emails
content@stockhead.com.au
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Tim Boreham - Stockhead’s resident health and biotechnology expert, Tim Boreham writes the weekly Dr Boreham’s Crucible column. He previously authored The Australian newspaper’s Criterion column for more than 10...
David Stamler - Alterity Therapeutics’ Ath434 Treatment, Phase 2 Results, The Planned Phase 3 Trial, Neurodegenerative Disease, And Regulatory Milestones
Zane Yoshida - Kava-based Products, Alcohol-free Beverages, Consumer Preferences, International Expansion, And Functional Beverages
James Agnew - Aroa Biosurgery And Its Health And Biotechnology Business
Singular Health targets US growth as Florida deal opens doors
October 09, 2026
Singular Health Group (ASX: SHG) is taking its 3DICOM medical imaging platform into the US healthcare market, with a major Florida project and a growing pipeline of commercial opportunities. In this Health Kick podcast, CEO Denning Chong explains how the company aims to reduce duplicate scans, expand healthcare partnerships and turn pilot programs into recurring revenue. Hear about Singular’s US$3 million Florida initiative, its commercialisation strategy and its ambitions for revenue growth ...
Alterity advances ATH434 toward pivotal phase three MSA trial
July 01, 2026
Alterity Therapeutics is entering a pivotal phase as it prepares for a global Phase 3 trial of ATH434, a potential first-in-class treatment for multiple system atrophy. In this episode, CEO David Stamler discusses promising Phase 2 results, the science behind targeting toxic brain iron, upcoming regulatory milestones and why ATH434 could become a breakthrough therapy for patients facing a devastating neurodegenerative disease. Learn more about your ad choices. Visit megaphone.fm/adchoices
The Calmer Co eyes growth in the Alcohol-Free market
June 28, 2026
As consumers increasingly seek alternatives to alcohol, The Calmer Co is working to broaden awareness and accessibility of kava-based products in Australia and overseas. CEO Zane Yoshida joins Tim Boreham to discuss the company's latest product launch, changing consumer preferences, growth opportunities in key markets, and the role kava could play in the expanding wellness and functional beverage sectors. Learn more about your ad choices. Visit megaphone.fm/adchoices
The AUScelerate Podcast · Low booking difficulty · 100 - 1,000 listeners
First in Human · Medium booking difficulty · 100 - 1,000 listeners
The Health Kick Podcast with Tim Boreham is hosted by Tim Boreham. Its publicly listed email is content@stockhead.com.au. For guest bookings, the host or producer is usually the best person to reach. Podseeker helps you find direct host and producer contacts and pitch from your own inbox.
The publicly listed email for The Health Kick Podcast with Tim Boreham: content@stockhead.com.au.
Podseeker estimates The Health Kick Podcast with Tim Boreham reaches 100 to 1,000 listeners per episode. Only the publisher has exact numbers.
The Health Kick Podcast with Tim Boreham typically books industry leaders. Typical guest background: Chief executives, chief financial officers, and other senior leaders of health, biotechnology, pharmaceutical, medical-device, and drug-development companies. Common among recent guests: Leading a health or biotechnology company; Advancing a drug, medical device, or other healthcare product; Reaching significant clinical, regulatory, commercial, or market milestones. Recent guests include David Stamler, Zane Yoshida, and James Agnew.
Medium. Guests usually need solid credentials in the topic and an idea that fits the show.
Recent episodes cover Biotechnology, Healthcare, Drug Discovery, Pharmaceuticals, and Medical Devices. Pitch an idea tied to one of these topics and mention a recent episode.
From public sources and our own research: podcast websites, social profiles, podcast feeds, and our data team. Podcast feeds and episodes are checked daily, and details like contacts, recent guests, and booking difficulty are refreshed regularly.
If something here is out of date, ask us to correct it through Podseeker's contact form at podseeker.co/contact. Our research team reviews every request and updates the listing.
Publicly listed emails
content@stockhead.com.au
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings